Skip to main content
1-featuredimage

Welcome to hubXchange's CNS Discovery Xchange Boston 2026.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Target Discovery, Disease Models, Novel ModalitiesBlood Brain Barrier,  and Biomarkers in Discovery

Attendees can engage in roundtable discussions, pre-booked 1:1 meetingspresentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate CNS Discovery.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking.

Boston | Tuesday 5th May 2026 | 08:00am - 05:45pm

VIEW AGENDA    REGISTER FOR FREE    OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

 

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
08:30
  1. 60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
09:05
  1. Target Discovery
    60 mins
    • Target Discovery
  2. Disease Models
    60 mins
    • Disease Models
    What are the appropriate scaling factors from preclinical models to humans, and what factors should be taken into account (e.g., brain volume, CSF, body size, etc.)? What are the differences in CSF fl ...
  3. Novel Modalities
    60 mins
    • Novel Modalities
  4. Blood Brain Barrier
    60 mins
    • Blood Brain Barrier
    How can we address the challenge of low BBB-permeability biologics? Can the cribriform plate and olfactory nerve route be used to bypass the BBB, and how effective is it? What do preclinical studies s ...
  5. Biomarkers in Discovery
    60 mins
    • Biomarkers in Discovery
    What new and emerging biomarker modalities show the most promise for improving disease detection, prognosis, or treatment response? How can big data and multi-omics approaches be leveraged to better d ...
10:10
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
10:40
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
11:10
  1. Morning Refreshments
    10 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
11:20
  1. Target Discovery
    60 mins
    • Target Discovery
  2. Disease Models
    60 mins
    • Disease Models
  3. Novel Modalities
    60 mins
    • Novel Modalities
     
  4. Blood Brain Barrier
    60 mins
    • Blood Brain Barrier
  5. Biomarkers in Discovery
    60 mins
    • Biomarkers in Discovery
12:20
  1. Networking Lunch
    60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
13:25
  1. 30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
14:00
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
14:30
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
15:35
  1. Afternoon Refreshments
    10 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery
15:45
  1. Target Discovery
    60 mins
    • Target Discovery
    What experimental designs are required to transform novel findings into robust preclinical datasets that withstand rigorous scrutiny regarding clinical translatability? How can research programs simul ...
  2. Disease Models
    60 mins
    • Disease Models
  3. Novel Modalities
    60 mins
    • Novel Modalities
  4. Blood Brain Barrier
    60 mins
    • Blood Brain Barrier
    What are the current CNS delivery approaches for gene therapies? How can gene therapies be specifically targeted within the CNS? What gene therapy approaches are used across various CNS indications?
  5. Biomarkers in Discovery
    60 mins
    • Biomarkers in Discovery
16:45
  1. Evening Drinks Reception
    60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
    • Biomarkers in Discovery

EVENT INFORMATION

3-featuredimage

DATES

Boston
5 May 2026
Tuesday 5th May 2026

 

Hilton Woburn Hotel

VENUE

Hilton Munich Airport Hotel

2 Forbes Rd
Woburn
MA 01801
United States

MAP

EVENT PARTNERS

4-featuredimage

EVENT PARTNERS

REGISTRATION FORM - Register for free!

6-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.